Outset Medical, Inc. (OM) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
OM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 39.1% | -55.8% | -68.3% |
| 2024 | 33.9% | -99.7% | -112.6% |
| 2023 | 22.2% | -130.2% | -132.5% |
| 2022 | 15.5% | -139.6% | -141.2% |
| 2021 | 7.4% | -127.2% | -128.6% |
Download Data
Export OM earnings history in CSV or JSON format
Free sign-in required to download data
Outset Medical, Inc. (OM) Earnings Overview
As of May 8, 2026, Outset Medical, Inc. (OM) reported trailing twelve-month net income of -$75M, reflecting +85.5% year-over-year growth. The company earned $-4.07 per diluted share over the past four quarters, with a net profit margin of -68.3%.
Looking at the long-term picture, OM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$50M in fiscal 2018.
Outset Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including DVA ($781M net income, 5.5% margin), FMS ($947M net income, 5.0% margin), HCAT (-$178M net income, -57.2% margin), OM has room to improve margins relative to the peer group. Compare OM vs DVA →
OM Earnings vs Peers
Earnings metrics vs comparable public companies
OM Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$82M | +36.2% | -$67M | $-5.37 | -68.3% | -55.8% |
| 2024 | -$128M | +25.9% | -$113M | $-36.95 | -112.6% | -99.7% |
| 2023 | -$173M | -6.0% | -$170M | $-52.27 | -132.5% | -130.2% |
| 2022 | -$163M | -23.5% | -$161M | $-50.75 | -141.2% | -139.6% |
| 2021 | -$132M | -8.6% | -$131M | $-43.41 | -128.6% | -127.2% |
| 2020 | -$121M | -77.9% | -$117M | $-2.83 | -243.3% | -235.2% |
| 2019 | -$68M | -37.2% | -$70M | $-34.06 | -453.0% | -466.3% |
| 2018 | -$50M | - | -$47M | $-1.65 | -2480.3% | -2320.0% |
See OM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOM — Frequently Asked Questions
Quick answers to the most common questions about buying OM stock.
Is OM growing earnings?
OM EPS is $-4.07, with earnings growth accelerating to +85.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-75M.
What are OM's profit margins?
Outset Medical, Inc. net margin is -68.3%, with operating margin at -55.8%. Below-average margins reflect competitive or cost pressures.
How consistent are OM's earnings?
OM earnings data spans 2018-2025. The accelerating earnings trend is +85.5% YoY. Historical data enables comparison across business cycles.